Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bon Announces Breakthrough Order for $16 Million Gut-Health Products 2025-07-02 20:00
[iNtRON] Files U.S. Patent for Three Novel Endolysin-Based Drug Candidates Targeting Gram-Negative Bacteria 2025-07-02 20:00
Arbele Wins Top Prize at BCIC's 4th Annual Biomedical Pitch Competition 2025-07-02 16:19
WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing 2025-07-01 17:44
HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach 2025-07-01 13:40
Noul Publishes Its Fifth Sustainability Report, Outlining a Vision for Growth and a Decade of Breakthroughs 2025-06-30 21:00
Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer's disease trial and interim analysis timeline 2025-06-30 20:30
Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals 2025-06-30 20:00
WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL 2025-06-30 19:00
Innovent Biologics Showcases "Dual Innovations" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms 2025-06-30 12:04
Innovent Announces Mazdutide, First Dual GCG/GLP-1 Receptor Agonist, Received Approval from China's NMPA for Chronic Weight Management 2025-06-27 17:49
Drug-Free Nasal Spray LUCA V-Defense Creates a Protective Shield Against Viruses and Allergies 2025-06-27 16:07
MGI ANNOUNCES PARTNERSHIP WITH NEGEDIA: ENHANCE GENOMIC SEQUENCING TECHNOLOGIES AT THE SERVICE OF SCIENTIFIC RESEARCH AND PRECISION MEDICINE IN ITALY 2025-06-27 10:46
WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity 2025-06-27 08:00
Origin Agritech Announced Financial Results for the Six Months Ended March 31, 2025 2025-06-27 04:15
SineuGene's SNUG01 Receives FDA Orphan Drug Designation for ALS 2025-06-26 22:04
Alebund Announces Positive Topline Results from Pivotal Phase 3 Study of AP301 for Serum Phosphorus Control in Dialysis Patients with Hyperphosphatemia 2025-06-26 20:00
Angel Yeast Set to Open Baiyang Biotechnology Park in Yichang in September 2025-06-26 20:00
BioCity's ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria 2025-06-26 08:38
Medeologix Sets New Standard with 3-Week Lead Time for PET Heat Shrink Tubing 2025-06-25 23:00
1 16 17 18 19 20 262